Maze Therapeutics MAZE
NASDAQ MAZE
$26.64 -0.01 (-0.06%)
As of: Oct 2, 2026 · 12:53 PM EDT

Maze Therapeutics (MAZE) Return on Assets [ROA] (2025 - 2026)

Updated

Maze Therapeutics (MAZE) posted Return on Assets [ROA] of -28.08% for Q2 2026, up 9.88 percentage points from -37.97% a year earlier and up 1.92 percentage points from the prior quarter.

Analysis

Maze Therapeutics (MAZE) Return on Assets [ROA] (2025 - 2026) Analysis & Trends

For FY2025, Maze Therapeutics' Return on Assets [ROA] came in at -41.12%.

  • The Q2 2026 figure stands as the highest quarterly Return on Assets [ROA] since Q1 2025.
  • According to Business Quant data, Return on Assets [ROA] for the three prior quarters was -30.00% (Q1 2026), -32.01% (Q4 2025) and -34.77% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 10.47%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 4.65%
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 2.45%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 28.37%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 9.10%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 9.29%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -6.13%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 2.14%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 16.34%
10 Maze Therapeutics 1.51 Bn 1.51 Bn - -28.08%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -28.08%
Mar 31, 2026 -30.00%
Dec 31, 2025 -32.01%
Sep 30, 2025 -34.77%
Jun 30, 2025 -37.97%
Mar 31, 2025 18.11%
API Access

Maze Therapeutics Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=MAZE&period=max&api_key=YOUR_API_KEY